E Musch

Summary

Affiliation: Marienhospital Bottrop
Country: Germany

Publications

  1. ncbi request reprint [Hypereosinophilia as the leading symptom in a patient with mastocytosis]
    Eugen Musch
    Abteilung fur Innere Medizin, Marienhospital, Bottrop
    Med Klin (Munich) 100:286-7. 2005
  2. ncbi request reprint Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial
    E Musch
    Department of Internal Medicine, Marienhospital Bottrop, Germany
    Aliment Pharmacol Ther 16:1233-9. 2002
  3. ncbi request reprint Amifostine plus erythropoietin in a patient with low-risk myelodysplastic syndrome
    E Musch
    Department of General Internal Medicine, Marienhospital Bottrop, Joret Albers Str 70, 46236 Bottrop, Germany
    Ann Hematol 82:244-6. 2003
  4. ncbi request reprint Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial
    E Musch
    Department of Internal Medicine, Marienhospital Bottrop, Germany
    Z Gastroenterol 45:1235-40. 2007
  5. ncbi request reprint Successful long-term application of highly purified natural interferon-alpha (multiferon) after preceding interferon approaches in a chronic hepatitis C patient with thrombocytopenia
    Eugen Musch
    Department of General Internal Medicine, Marienhospital Bottrop gGmbH, Germany
    Scand J Infect Dis 36:395-9. 2004
  6. ncbi request reprint Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches
    Eugen Musch
    Department of General Internal Medicine, Marienhospital Bottrop gGmbH, Germany
    Hepatogastroenterology 51:1476-9. 2004
  7. ncbi request reprint Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial
    Eugen Musch
    Department of Internal Medicine, Marienhospital Bottrop, Bottrop, Germany
    Clin Gastroenterol Hepatol 3:581-6. 2005
  8. ncbi request reprint [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?]
    E Musch
    Marienhospital Bottrop, Abteilung fur Innere Medizin, Bottrop
    Dtsch Med Wochenschr 131:1214-7. 2006
  9. ncbi request reprint Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease
    A Chrissafidou
    Marienhospital Bottrop, Abteilung fur Innere Medizin, Bottrop, Germany
    Z Gastroenterol 45:605-8. 2007
  10. doi request reprint [Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C]
    A Chrissafidou
    Abteilung fur Innere Medizin, Marienhospital Bottrop
    Dtsch Med Wochenschr 134:927-30. 2009

Detail Information

Publications12

  1. ncbi request reprint [Hypereosinophilia as the leading symptom in a patient with mastocytosis]
    Eugen Musch
    Abteilung fur Innere Medizin, Marienhospital, Bottrop
    Med Klin (Munich) 100:286-7. 2005
  2. ncbi request reprint Induction and maintenance of clinical remission by interferon-beta in patients with steroid-refractory active ulcerative colitis-an open long-term pilot trial
    E Musch
    Department of Internal Medicine, Marienhospital Bottrop, Germany
    Aliment Pharmacol Ther 16:1233-9. 2002
    ..Shifting this disturbed ratio by means of TNF-antibodies or interferon has been shown to be helpful in treating Crohn's disease and multiple sclerosis, respectively...
  3. ncbi request reprint Amifostine plus erythropoietin in a patient with low-risk myelodysplastic syndrome
    E Musch
    Department of General Internal Medicine, Marienhospital Bottrop, Joret Albers Str 70, 46236 Bottrop, Germany
    Ann Hematol 82:244-6. 2003
    ..The patient experienced a good general clinical condition without further need for hospitalization or blood transfusions...
  4. ncbi request reprint Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial
    E Musch
    Department of Internal Medicine, Marienhospital Bottrop, Germany
    Z Gastroenterol 45:1235-40. 2007
    ..0 vs. 0.5 MIU) could result in fewer relapse events...
  5. ncbi request reprint Successful long-term application of highly purified natural interferon-alpha (multiferon) after preceding interferon approaches in a chronic hepatitis C patient with thrombocytopenia
    Eugen Musch
    Department of General Internal Medicine, Marienhospital Bottrop gGmbH, Germany
    Scand J Infect Dis 36:395-9. 2004
    ..After the patient was switched to highly purified natural IFN-alpha (Multiferon) the thrombocyte and leukocyte counts increased significantly, and sustained complete biochemical and virological response could be achieved...
  6. ncbi request reprint Successful application of highly purified natural interferon alpha (multiferon) in a chronic hepatitis C patient resistant to preceding treatment approaches
    Eugen Musch
    Department of General Internal Medicine, Marienhospital Bottrop gGmbH, Germany
    Hepatogastroenterology 51:1476-9. 2004
    ....
  7. ncbi request reprint Interferon-beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomized, double-blind, placebo-controlled trial
    Eugen Musch
    Department of Internal Medicine, Marienhospital Bottrop, Bottrop, Germany
    Clin Gastroenterol Hepatol 3:581-6. 2005
    ..We performed a randomized, double-blind, placebo-controlled, multicenter trial to investigate the efficacy and safety of recombinant interferon-beta-1a (rIFN-beta-1a) in outpatients with active steroid-refractory ulcerative colitis...
  8. ncbi request reprint [Acute hepatitis due to kava-kava and St John's Wort: an immune-mediated mechanism?]
    E Musch
    Marienhospital Bottrop, Abteilung fur Innere Medizin, Bottrop
    Dtsch Med Wochenschr 131:1214-7. 2006
    ..Biopsy of the liver showed lobular and portal necroinflammatory activity without indication of cirrhosis...
  9. ncbi request reprint Experimental study on the use of intravenous immunoglobulin (IVIg) in patients with steroid-resistant Crohn's disease
    A Chrissafidou
    Marienhospital Bottrop, Abteilung fur Innere Medizin, Bottrop, Germany
    Z Gastroenterol 45:605-8. 2007
    ..Over time, however, approx. 20 % of patients develop steroid resistance. In these cases, alternative treatment methods are required. Short-term application of intravenous immunoglobulin (IVIg) may serve as an additional alternative...
  10. doi request reprint [Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C]
    A Chrissafidou
    Abteilung fur Innere Medizin, Marienhospital Bottrop
    Dtsch Med Wochenschr 134:927-30. 2009
    ..A 54-year-old female patient with recently confirmed chronic hepatitis C, genotype Ib and positive HCV-RNA was admitted for interferon induction therapy...
  11. ncbi request reprint Palliation by intratumoral infiltration with natural interferon-beta
    E Musch
    Allgemeine Innere Medizin, Marienhospital Bottrop, Bottrop, Germany
    Onkologie 24:362-6. 2001
    ..CONCLUSION: From these observations, intralesional nIFN-beta therapy of malignant tumors appears to be a useful palliative addition to radio- and/or chemotherapy with the aim of local control of tumor growth...
  12. ncbi request reprint Intrapericardial instillation of mitoxantrone in palliative therapy of malignant pericardial effusion
    E Musch
    Allgemeine Innere Medizin, Marienhospital Bottrop, Germany
    Onkologie 26:135-9. 2003
    ..Following our positive experiences with mitoxantrone in the treatment of malignant pleural effusions, we applied this substance for the therapy of malignant pericardial effusions...